BOSTON — A study of atropine eye drops to delay the onset of pediatric myopia has received federal grants totaling $25 million and will be conducted by researchers at the University of Houston and The Ohio State University.
“A study like this has never been conducted in the United States,” David A. Berntsen, OD, PhD, FAAO, coprincipal investigator and Golden-Golden Professor of Optometry at the University of Houston, told Healio during Academy 2025. “If we’re able to find these kids and provide a treatment that’s able to delay when they become nearsighted, our hope is that we can decrease how